Nonhuman Primate Self-Administration in Assessments of Abuse Potential

Paul W. Czoty, Matthew L. Banks, Michael A. Nader, Charles P France

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Studies of drug self-administration and dependence in laboratory animals are critical components in the Food and Drug Administration's assessment of the abuse potential of drugs. This chapter describes the use of nonhuman primates (NHPs) for such assessments. NHPs are more similar to humans in brain anatomy, connectivity, and neurochemistry than other species, particularly in the brain areas that mediate the reinforcing effects of drugs. As a result of being closely phylogenetically related to humans, NHPs are often the most appropriate species for modeling the pharmacokinetics of drugs in humans. From an experimental perspective, the use of NHPs permits longitudinal studies in which several variables can be manipulated over an extended period of time to more fully assess the abuse potential of a drug and the long-term consequences of drug treatment. Moreover, the sophisticated behavioral and cognitive repertoire of monkeys renders them preferred subjects for studies that use complex schedules of reinforcement that best model the conditions in which humans abuse drugs.

Original languageEnglish (US)
Title of host publicationNonclinical Assessment of Abuse Potential for New Pharmaceuticals
PublisherElsevier Inc.
Pages81-99
Number of pages19
ISBN (Electronic)9780124202160
ISBN (Print)9780124201729
DOIs
StatePublished - Aug 7 2015

    Fingerprint

Keywords

  • Dependence
  • Nonhuman primate
  • Pharmacokinetics
  • Schedule-controlled behavior
  • Self-administration
  • Withdrawal

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Czoty, P. W., Banks, M. L., Nader, M. A., & France, C. P. (2015). Nonhuman Primate Self-Administration in Assessments of Abuse Potential. In Nonclinical Assessment of Abuse Potential for New Pharmaceuticals (pp. 81-99). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-420172-9.00004-7